PRRX2 and central nervous system cancer: CircLRFN5 interacts with PRRX2 and promotes its ubiquitination and proteasomal degradation, transcriptionally reducing PRRX2-mediated GCH1 expression, resulting in the induction of ferroptosis in glioma [170].